438 related articles for article (PubMed ID: 25894568)
1. Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients.
Paredes-Turrubiarte G; González-Chávez A; Pérez-Tamayo R; Salazar-Vázquez BY; Hernández VS; Garibay-Nieto N; Fragoso JM; Escobedo G
Clin Exp Med; 2016 May; 16(2):193-202. PubMed ID: 25894568
[TBL] [Abstract][Full Text] [Related]
2. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
[TBL] [Abstract][Full Text] [Related]
3. IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients.
García-Galiano D; Sánchez-Garrido MA; Espejo I; Montero JL; Costán G; Marchal T; Membrives A; Gallardo-Valverde JM; Muñoz-Castañeda JR; Arévalo E; De la Mata M; Muntané J
Obes Surg; 2007 Apr; 17(4):493-503. PubMed ID: 17608262
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease.
Waluga M; Kukla M; Zorniak M; Kajor M; Liszka L; Dyaczynski M; Kowalski G; Zadlo D; Waluga E; Olczyk P; Buldak RJ; Berdowska A; Hartleb M
J Physiol Pharmacol; 2017 Jun; 68(3):363-374. PubMed ID: 28820393
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients.
Gentili A; Daviddi G; De Vuono S; Ricci MA; Di Filippo F; Alaeddin A; Mannarino MR; Boni M; Vaudo G; Lupattelli G
Dig Liver Dis; 2016 Aug; 48(8):904-8. PubMed ID: 27160697
[TBL] [Abstract][Full Text] [Related]
6. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L
Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055
[TBL] [Abstract][Full Text] [Related]
7. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
9. Reduced systemic levels of IL-10 are associated with the severity of obstructive sleep apnea and insulin resistance in morbidly obese humans.
Leon-Cabrera S; Arana-Lechuga Y; Esqueda-León E; Terán-Pérez G; Gonzalez-Chavez A; Escobedo G; Velázquez Moctezuma J
Mediators Inflamm; 2015; 2015():493409. PubMed ID: 25944984
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F
Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092
[TBL] [Abstract][Full Text] [Related]
11. Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Aragonès G; Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Armengol S; Sabench F; Ras R; Hernandez M; Aguilar C; Colom J; Sirvent JJ; Del Castillo D; Richart C
PLoS One; 2016; 11(4):e0154601. PubMed ID: 27123846
[TBL] [Abstract][Full Text] [Related]
12. Insulin Resistance, but Not Obstructive Sleep Apnea Is Associated with Hepatic Steatosis in Chinese Patients with Severe Obesity.
Zhu C; Tang S; Xiao J; Zhang Y; Sun L; Zhang J; Ding L; Liu M
Obes Facts; 2023; 16(4):344-355. PubMed ID: 36854279
[TBL] [Abstract][Full Text] [Related]
13. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
Mager DR; Iñiguez IR; Gilmour S; Yap J
JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
[TBL] [Abstract][Full Text] [Related]
14. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
[TBL] [Abstract][Full Text] [Related]
15. CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY.
Barros F; Setúbal S; Martinho JM; Ferraz L; Gaudêncio A
Arq Bras Cir Dig; 2016; 29(4):260-263. PubMed ID: 28076482
[TBL] [Abstract][Full Text] [Related]
16. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
[TBL] [Abstract][Full Text] [Related]
17. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease.
Jamali R; Razavizade M; Arj A; Aarabi MH
World J Gastroenterol; 2016 Jun; 22(21):5096-103. PubMed ID: 27275102
[TBL] [Abstract][Full Text] [Related]
18. CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.
Rość D; Adamczyk P; Boinska J; Szafkowski R; Ponikowska I; Stankowska K; Góralczyk B; Ruszkowska-Ciastek B
J Zhejiang Univ Sci B; 2015 May; 16(5):404-11. PubMed ID: 25990058
[TBL] [Abstract][Full Text] [Related]
19. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
20. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease.
Poniachik J; Csendes A; Díaz JC; Rojas J; Burdiles P; Maluenda F; Smok G; Rodrigo R; Videla LA
Cytokine; 2006 Mar; 33(5):252-7. PubMed ID: 16564703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
